| Literature DB >> 22622428 |
Daisuke Suzuki1, Makoto Senoo2.
Abstract
Entities:
Mesh:
Substances:
Year: 2012 PMID: 22622428 PMCID: PMC3434241 DOI: 10.1038/jid.2012.165
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551
Figure 1Expression of p63 and pp63 in human epidermis and cultured keratinocytes
(a) Immunofluorescence staining of normal human epidermis for p63, pp63 and integrin β4. Insets and lower panels are enlarged views of representative suprabasal (S) and basal (B) cells, respectively. Arrowheads and arrows indicate representative p63hi cells with relatively low and high p63 phosphorylation, respectively; DNA, nuclear counterstaining; Bars=20μm.
(b) Comparison of the p63 levels normalized by nuclear counterstaining between the basal (integrin β4+, n=58) and the suprabasal (integrin β4−, n=192) cells from a single image by box-and-whisker plots. Shown are representative data from three independent experiments with similar results.
(c) Histogram of the pp63/p63 ratio among p63hi cells (top 50% in (b)). *, not detectable.
(d) Western blot analysis of Ca2+-induced differentiation of HPEKs.
(e) Quantification of (d) for the changes in p63 levels and the pp63/p63 ratio with time.
Figure 2pp63 levels and the proliferative potential of epidermal SCs
(a) Immunofluorescence staining of holoclones for p63 and pp63. Dotted lines indicate the clone border. Bars=50μm.
(b) Left, Expression of p63 and pp63 in the peripheral and central cells isolated from holoclones. Right, Comparison of the pp63/p63 ratios between the peripheral (n=83) and the central (n=74) cells by box-and-whisker plots. DNA, nuclear counterstaining; Bar=20μm; **, p<0.01.
(c) Western blot analysis of p63, pp63 and CK14 levels in the peripheral (p) and central (c) cells from holoclones and whole (w) meroclone-forming cells.
(d) Quantification of the pp63/p63 ratio from the data shown in (c). **, p<0.01.
(e) Representative data for the proliferative potential of cells isolated from the periphery and the center of holoclones at passage 3.
(f) Comparison of holoclone-forming efficiency between peripheral and central cells at different passages (n=3). *, p<0.05; **, p<0.01.